Kouremeti M, Iliakis P, Konstantinidis D, Polyzos D, et al. EPLERENONE VS IRBESARTAN AS FIRST LINE THERAPY IN OBESE HYPERTENSIVE PATIENTS: PRELIMINARY RESULTS FROM HEBRO STUDY. J Hypertens 2022;40.
PMID: 36027426